Immune Mechanisms of Pulmonary Fibrosis with Bleomycin

被引:46
|
作者
Ishida, Yuko [1 ]
Kuninaka, Yumi [1 ]
Mukaida, Naofumi [1 ]
Kondo, Toshikazu [1 ]
机构
[1] Wakayama Med Univ, Dept Forens Med, 811-1 Kimiidera, Wakayama 6418509, Japan
基金
日本学术振兴会;
关键词
pulmonary fibrosis; idiopathic pulmonary fibrosis; bleomycin; inflammation; cytokines; chemokines; growth factors; wound healing; EPITHELIAL-MESENCHYMAL TRANSITION; TISSUE GROWTH-FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; MESSENGER-RNA EXPRESSION; HUMAN LUNG FIBROBLASTS; C-C CHEMOKINES; TGF-BETA; MATRIX METALLOPROTEINASES; STEM-CELLS; GENE-EXPRESSION;
D O I
10.3390/ijms24043149
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fibrosis and structural remodeling of the lung tissue can significantly impair lung function, often with fatal consequences. The etiology of pulmonary fibrosis (PF) is diverse and includes different triggers such as allergens, chemicals, radiation, and environmental particles. However, the cause of idiopathic PF (IPF), one of the most common forms of PF, remains unknown. Experimental models have been developed to study the mechanisms of PF, and the murine bleomycin (BLM) model has received the most attention. Epithelial injury, inflammation, epithelial-mesenchymal transition (EMT), myofibroblast activation, and repeated tissue injury are important initiators of fibrosis. In this review, we examined the common mechanisms of lung wound-healing responses after BLM-induced lung injury as well as the pathogenesis of the most common PF. A three-stage model of wound repair involving injury, inflammation, and repair is outlined. Dysregulation of one or more of these three phases has been reported in many cases of PF. We reviewed the literature investigating PF pathogenesis, and the role of cytokines, chemokines, growth factors, and matrix feeding in an animal model of BLM-induced PF.
引用
收藏
页数:31
相关论文
共 50 条
  • [1] Immune Mechanisms in Pulmonary Fibrosis
    Kolahian, Saeed
    Fernandez, Isis E.
    Eickelberg, Oliver
    Hartl, Dominik
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2016, 55 (03) : 309 - 322
  • [2] Modeling pulmonary fibrosis with bleomycin
    Mouratis, Marios A.
    Aidinis, Vassilis
    CURRENT OPINION IN PULMONARY MEDICINE, 2011, 17 (05) : 355 - 361
  • [3] Mefunidone Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
    Han, Yuanyuan
    Jiang, Mao
    He, Rongling
    Lv, Xin
    Liao, Xiaohua
    He, Yijun
    Zhang, Fan
    Long, Lingzhi
    Jiang, Guoliang
    Peng, Zhangzhe
    Tao, Lijian
    Hu, Gaoyun
    Meng, Jie
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [4] Pirfenidone activates cannabinoid receptor 2 in a mouse model of bleomycin-induced pulmonary fibrosis
    Liu, Jinhong
    Shi, Guiling
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (06) : 4241 - 4248
  • [5] Thrombospondin-1-Deficient Mice Are Not Protected from Bleomycin-Induced Pulmonary Fibrosis
    Ezzie, Michael E.
    Piper, Melissa G.
    Montague, Christine
    Newland, Christie A.
    Opalek, Judy M.
    Baran, Chris
    Ali, Naeem
    Brigstock, David
    Lawler, Jack
    Marsh, Clay B.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2011, 44 (04) : 556 - 561
  • [6] Metformin alleviates bleomycin-induced pulmonary fibrosis in rats: Pharmacological effects and molecular mechanisms
    Gamad, Nanda
    Malik, Salma
    Suchal, Kapil
    Vasisht, Swati
    Tomar, Ameesha
    Arava, Sudheer
    Arya, Dharamvir Singh
    Bhatia, Jagriti
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 97 : 1544 - 1553
  • [7] Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice
    Jin, Ming
    Wu, Yan
    Wang, Lin
    Zang, Baoxia
    Tan, Li
    PHYTOTHERAPY RESEARCH, 2016, 30 (04) : 577 - 587
  • [8] INHIBITORY EFFECT OF EMODIN ON BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN MICE
    Chen, Xiao-Hong
    Sun, Ren-Shan
    Hu, Jian-Ming
    Mo, Zi-Yao
    Yang, Zi-Feng
    Jin, Guang-Yao
    Guan, Wen-Da
    Zhong, Nan-Shan
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2009, 36 (02): : 146 - 153
  • [9] Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model
    Comeglio, P.
    Filippi, S.
    Sarchielli, E.
    Morelli, A.
    Cellai, I.
    Corno, C.
    Pini, A.
    Adorini, L.
    Vannelli, G. B.
    Maggi, M.
    Vignozzi, L.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (03) : 283 - 294
  • [10] Effects of simvastatin on pulmonary fibrosis, pulmonary hypertension and exercise capacity in bleomycin-treated rats
    Schroll, S.
    Lange, T. J.
    Arzt, M.
    Sebah, D.
    Nowrotek, A.
    Lehmann, H.
    Wensel, R.
    Pfeifer, M.
    Blumberg, F. C.
    ACTA PHYSIOLOGICA, 2013, 208 (02) : 191 - 201